Molecular Imaging: Page 2

Dual-targeting PET tracer begins to show its stripes
New evidence suggests that PET/CT imaging with a gallium-68 (Ga-68)-labeled heterodimeric radiotracer is highly effective for visualizing various types of malignant cancer, according to a group in China.
September 12, 2023
2023 09 12 21 01 4070 2023 09 13 Lnc1007
Kromek highlights Spectrum's integration of its detectors
Radiation technology developer Kromek Group is highlighting that Spectrum Dynamics Medical has introduced Veriton-CT 300, which incorporated Kromek's digital detectors.
September 11, 2023
2020 05 29 22 07 5044 Ct Scanner Bore 400
PET imaging predicts long-term outcomes in Parkinson's disease
PET brain imaging in individuals with early Parkinson's disease can show which patients are at higher risk of long-term effects, according to a study by researchers in Italy.
September 11, 2023
2021 06 09 23 42 6597 Parkinsons Torn Newspaper 400
FAPI-PET/CT may improve treatment of cancer patients
Gallium-68 (Ga-68) FAPI-PET/CT imaging -- a highly accurate experimental approach for detecting cancer -- may further improve outcomes for patients undergoing radiation therapy, according to a recent analysis by German researchers.
September 11, 2023
2023 09 11 22 52 0346 2023 09 11 Fapi 20230911224724
FDA clears Xeos Aura 10 PET-CT specimen imaging system
The U.S. Food and Drug Administration (FDA) has approved Xeos' Aura 10 PET-CT specimen imaging system for the operating room.
September 10, 2023
2019 02 13 19 24 5396 Fda Logo V2 400
Eczacıbaşı-Monrol to expand Lu-177 production
Turkish radiopharmaceutical company Eczacıbaşı-Monrol plans to expand its Lutetium-177 (Lu-177) production capacity.
September 10, 2023
2017 08 16 13 40 50 749 Graph Arrow Up 400
PET/CT-based model predicts prostate cancer in the 'PSA grey zone'
Combining PET/CT with traditional clinical risk factors can detect prostate cancer in cases considered borderline based on prostate-specific antigen (PSA) levels -- in other words, cases in the "PSA grey zone," according to a group in Hunan, China.
September 10, 2023
2023 09 08 15 10 4007 2023 09 08 Prostate Cancer 20230908154926
PET reveals link between heart health and brain metabolism
A PET study suggests that maintaining cardiovascular health during midlife can help reduce the risk of neurodegenerative disease later in life, according to a group in Spain.
September 6, 2023
2019 07 17 22 41 3854 Brain Puzzle Dementia 400
Telix touts studies at EANM 2023
Telix Pharmaceuticals is highlighting studies set to be presented at the European Association of Nuclear Medicine meeting to be held September 9-13 in Vienna.
September 5, 2023
2018 12 11 00 02 7009 Atom Nuclear Lab 400
FDOPA-PET/CT predicts survival in patients with midgut NETs
PET/CT imaging with F-18 fluorodopa (FDOPA) is an effective approach for detecting neuroendocrine tumors (NETs) -- and now the scans may be used to predict survival in patients with tumors in the midgut, according to researchers in France.
September 5, 2023
2023 09 05 17 32 1374 2023 09 05 Pet Ct Midgut Ne Ts 400
PET/CT and PET/MRI appear equivalent for diagnosing prostate cancer
PET/CT and PET/MRI have gone head-to-head for detecting prostate cancer relapse in a review that included 37 clinical studies and 8,709 patients -- with PET/MRI taking a slight lead, according to a team in China.
August 31, 2023
2019 04 17 20 48 2514 Prostate 3 D 400
Actinium to present three abstracts at SOHO 2023
Radiotherapy developer Actinium Pharmaceuticals will present three abstracts accepted for poster presentation at the Society of Hematologic Oncology (SOHO) 2023 annual meeting in Houston, TX, between September 6 and 9.
August 30, 2023
2020 07 23 21 58 4280 Cancer Radiotherapy 400
Previous Page
Page 2 of 587
Next Page